Li, Li, et al. “Efficacy and Safety of Osimertinib for Patients With EGFR-Mutated NSCLC: A Systematic Review and Meta-Analysis of Randomized Controlled Studies”. Acta Oncologica, vol. 61, no. 11, Nov. 2022, pp. 1347-53, doi:10.1080/0284186X.2022.2132116.